291 related articles for article (PubMed ID: 9544788)
21. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
22. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
23. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
[TBL] [Abstract][Full Text] [Related]
24. Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the rat.
Belzung C; Barreau S; Agmo A
Eur J Pharmacol; 2000 Apr; 394(2-3):289-94. PubMed ID: 10771294
[TBL] [Abstract][Full Text] [Related]
25. Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors.
Carter LP; Wu H; Chen W; Cruz CM; Lamb RJ; Koek W; Coop A; France CP
J Pharmacol Exp Ther; 2004 Jan; 308(1):182-8. PubMed ID: 14569056
[TBL] [Abstract][Full Text] [Related]
26. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
van Nieuwenhuijzen PS; McGregor IS
Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
[TBL] [Abstract][Full Text] [Related]
27. GABA and 5-HT systems are implicated in the anxiolytic-like effect of spinosin in mice.
Liu J; Zhai WM; Yang YX; Shi JL; Liu QT; Liu GL; Fang N; Li J; Guo JY
Pharmacol Biochem Behav; 2015 Jan; 128():41-9. PubMed ID: 25449359
[TBL] [Abstract][Full Text] [Related]
28. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
Wada T; Fukuda N
Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
[TBL] [Abstract][Full Text] [Related]
29. Biological profiling of piperazinediones for the management of anxiety.
Kumar D; Gupta SK; Ganeshpurkar A; Singh R; Kumar D; Das N; Krishnamurthy S; Singh SK
Pharmacol Biochem Behav; 2019 Jan; 176():63-71. PubMed ID: 30500330
[TBL] [Abstract][Full Text] [Related]
30. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat.
Godbout R; Jelenic P; Labrie C; Schmitt M; Bourguignon JJ
Brain Res; 1995 Feb; 673(1):157-60. PubMed ID: 7757470
[TBL] [Abstract][Full Text] [Related]
31. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
Wierońska JM; Papp M; Pilc A
Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
[TBL] [Abstract][Full Text] [Related]
32. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.
Garrett KM; Basmadjian G; Khan IA; Schaneberg BT; Seale TW
Psychopharmacology (Berl); 2003 Oct; 170(1):33-41. PubMed ID: 12845414
[TBL] [Abstract][Full Text] [Related]
33. [Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam].
Moldavkin GM; Voronina TA; Neznamov GG; Maletova OK; Eliava NV
Eksp Klin Farmakol; 2006; 69(3):7-9. PubMed ID: 16878489
[TBL] [Abstract][Full Text] [Related]
34. Anxiolytic-like effects of phytol: possible involvement of GABAergic transmission.
Costa JP; de Oliveira GA; de Almeida AA; Islam MT; de Sousa DP; de Freitas RM
Brain Res; 2014 Feb; 1547():34-42. PubMed ID: 24333358
[TBL] [Abstract][Full Text] [Related]
35. Anti-sedative and anti-cataleptic properties of NCS-382, a gamma-hydroxybutyrate receptor antagonist.
Schmidt C; Gobaille S; Hechler V; Schmitt M; Bourguignon JJ; Maitre M
Eur J Pharmacol; 1991 Oct; 203(3):393-7. PubMed ID: 1773824
[TBL] [Abstract][Full Text] [Related]
36. The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.
Chopin P; Briley M
Psychopharmacology (Berl); 1993; 110(4):409-14. PubMed ID: 7870910
[TBL] [Abstract][Full Text] [Related]
37. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
Wesołowska A
Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
[TBL] [Abstract][Full Text] [Related]
38. A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze.
Mansouri MT; Soltani M; Naghizadeh B; Farbood Y; Mashak A; Sarkaki A
Pharmacol Biochem Behav; 2014 Feb; 117():40-6. PubMed ID: 24345572
[TBL] [Abstract][Full Text] [Related]
39. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
Wiley JL; Cristello AF; Balster RL
Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
[TBL] [Abstract][Full Text] [Related]
40. A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus.
Gonzalez LE; File SE
J Neurosci; 1997 Feb; 17(4):1505-11. PubMed ID: 9006991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
